Your browser doesn't support javascript.
loading
Efficient Evaluation of In Vivo Performance in Human for Generic Formulation by Novel Dissolution-Absorption Prediction (DAP) Workflow.
Onishi, Motoki; Tagawa, Kozo; Jiko, Maiko; Koike, Kayo; Maruyama, Masato; Hashizume, Hidetoshi; Imagaki, Kazuhide; Higaki, Kazutaka.
Afiliación
  • Onishi M; Medical Analysis Research Department, Pharmaceutical Research & Technology Division, Towa Pharmaceutical Co., Ltd, Kyoto Research Park KISTIC #202, 134, Chudoji Minami-machi, Shimogyo-ku, Kyoto, Japan.
  • Tagawa K; Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-naka, Kita-ku, Okayama, 700-8530, Japan.
  • Jiko M; Department of Bio-Technology, Osaka Bio-Medical College, 1-14-30 Shimanouchi, Chuo-ku, Osaka, Japan.
  • Koike K; Medical Analysis Research Department, Pharmaceutical Research & Technology Division, Towa Pharmaceutical Co., Ltd, Kyoto Research Park KISTIC #202, 134, Chudoji Minami-machi, Shimogyo-ku, Kyoto, Japan.
  • Maruyama M; Medical Analysis Research Department, Pharmaceutical Research & Technology Division, Towa Pharmaceutical Co., Ltd, Kyoto Research Park KISTIC #202, 134, Chudoji Minami-machi, Shimogyo-ku, Kyoto, Japan.
  • Hashizume H; Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-naka, Kita-ku, Okayama, 700-8530, Japan.
  • Imagaki K; Medical Analysis Research Department, Pharmaceutical Research & Technology Division, Towa Pharmaceutical Co., Ltd, Kyoto Research Park KISTIC #202, 134, Chudoji Minami-machi, Shimogyo-ku, Kyoto, Japan.
  • Higaki K; Medical Analysis Research Department, Pharmaceutical Research & Technology Division, Towa Pharmaceutical Co., Ltd, Kyoto Research Park KISTIC #202, 134, Chudoji Minami-machi, Shimogyo-ku, Kyoto, Japan.
Pharm Res ; 39(9): 2203-2216, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35836039

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Medicamentos Genéricos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pharm Res Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Medicamentos Genéricos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pharm Res Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos